Other cancers found to express higher levels of CD46 than adjacent normal tissues, which also relates to a worse clinical prognosis, include hepatocellular carcinoma (HCC), colon cancer, and Multiple Myeloma (70–72). Here, CD46 is linked to hepatocellular carcinoma.